fda compounding semaglutide news november 2025 restricts non-approved compounded GLP-1 weight loss products Compounded Semaglutide: Legal & Safe
Description
A 2023 meta-analysis in Obesity Journal found modest but consistent benefits: 34 kg average weight loss at 6 months in app-based interventions versus control groups
At the end of the day, if youre trying to lose weight, consult a doctor before trying a new strategy or supplementno matter how promising it appears
However, they noted these benefits were a somewhat modest 10 to 20 percent reduction in most risks
Consult your healthcare provider for a comprehensive list
